Neurological Manifestations of Vascular Dementia Medication

1. Jellinger KA. Morphologic diagnosis of "vascular dementia" - a critical update. J Neurol Sci. 2008 Jul 15. 270(1-2):1-12. [QxMD MEDLINE Link].

2. Jellinger KA. The pathology of "vascular dementia": a critical update. J Alzheimers Dis. 2008 May. 14(1):107-23. [QxMD MEDLINE Link].

3. Schneck MJ. Vascular dementia. Top Stroke Rehabil. 2008 Jan-Feb. 15(1):22-6. [QxMD MEDLINE Link].

4. Srinivasan V, Braidy N, Chan EK, Xu YH, Chan DK. Genetic and Environmental Factors in Vascular Dementia: an update of blood brain barrier dysfunction. Clin Exp Pharmacol Physiol. 2016 Feb 9. [QxMD MEDLINE Link].

5. Solans-Laque R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Tarres M. Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature. Medicine (Baltimore). 2008 Nov. 87(6):335-44. [QxMD MEDLINE Link].

6. Anderson P. 6 Steps to nondrug management of dementia. Medscape Medical News. December 27, 2012. [Full Text].

7. Gitlin LN, Kales HC, Lyketsos CG. Nonpharmacologic management of behavioral symptoms in dementia. JAMA. 2012 Nov 21. 308(19):2020-9. [QxMD MEDLINE Link].

8. Bousser MG. Stroke prevention: an update. Front Med. 2012 Mar. 6(1):22-34. [QxMD MEDLINE Link].

9. Ancelin ML, Carrière I, Barberger-Gateau P, Auriacombe S, Rouaud O, Fourlanos S, et al. Lipid Lowering Agents, Cognitive Decline, and Dementia: The Three-City Study. J Alzheimers Dis. 2012 Mar 26. [QxMD MEDLINE Link].

10. Fischer P, Krampla W, Mostafaie N, Zehetmayer S, Rainer M, Jungwirth S, et al. VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly. J Neural Transm Suppl. 2007. 181-8. [QxMD MEDLINE Link].

11. Chen C, Homma A, Mok VC, Krishnamoorthy E, Alladi S, Meguro K, et al. Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region. J Intern Med. 2016 Mar 16. [QxMD MEDLINE Link].

12. Roach GW, Kanchuger M, Mangano CM. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med. 1996 Dec 19. 335(25):1857-63. [QxMD MEDLINE Link].

13. Ruchoux MM, Brulin P, Brillault J. Lessons from CADASIL. Ann N Y Acad Sci. 2002 Nov. 977:224-31. [QxMD MEDLINE Link].

14. Qian L, Ding L, Cheng L, Zhu X, Zhao H, Jin J, et al. Early biomarkers for post-stroke cognitive impairment. J Neurol. 2012 Mar 10. [QxMD MEDLINE Link].

15. Perrotta M, Lembo G, Carnevale D. Hypertension and Dementia: Epidemiological and Experimental Evidence Revealing a Detrimental Relationship. Int J Mol Sci. 2016 Mar 8. 17 (3):[QxMD MEDLINE Link].

16. Knopman DS, Rocca WA, Cha RH. Incidence of vascular dementia in Rochester, Minn, 1985-1989. Arch Neurol. 2002 Oct. 59(10):1605-10. [QxMD MEDLINE Link].

17. Erkinjuntti T. Vascular cognitive deterioration and stroke. Cerebrovasc Dis. 2007. 24 Suppl 1:189-94. [QxMD MEDLINE Link].

18. Rusanen M, Kivipelto M, Quesenberry CP Jr, Zhou J, Whitmer RA. Heavy Smoking in Midlife and Long-term Risk of Alzheimer Disease and Vascular Dementia. Arch Intern Med. 2010 Oct 25. [QxMD MEDLINE Link].

19. Mukamal KJ, Kuller LH, Fitzpatrick AL. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA. 2003 Mar 19. 289(11):1405-13. [QxMD MEDLINE Link].

20. Smith E. Vascular Cognitive Impairment. Continuum (Minneap Minn). 2016 Apr. 22 (2 Dementia):490-509. [QxMD MEDLINE Link].

21. Bowler JV. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease. Stroke. 2003 Feb. 34(2):584-6. [QxMD MEDLINE Link].

22. Bowler JV. Modern concept of vascular cognitive impairment. Br Med Bull. 2007. 83:291-305. [QxMD MEDLINE Link].

23. de Groot JC, de Leeuw FE, Oudkerk M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000 Feb. 47(2):145-51. [QxMD MEDLINE Link].

24. Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology. 2012 Feb 29. [QxMD MEDLINE Link].

25. Engelhart MJ, Geerlings MI, Ruitenberg A. Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology. 2002 Dec 24. 59(12):1915-21. [QxMD MEDLINE Link].

26. Freels S, Nyenhuis DL, Gorelick PB. Predictors of survival in African American patients with AD, VaD, or stroke without dementia. Neurology. 2002 Oct 22. 59(8):1146-53. [QxMD MEDLINE Link].

27. Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke. 2003 Feb. 34(2):335-7. [QxMD MEDLINE Link].

28. Knopman DS. Cerebrovascular pathology in cognitive impairment: New (in)sights. Neurology. 2012 Feb 29. [QxMD MEDLINE Link].

29. Knopman DS, Rocca WA, Cha RH. Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol. 2003 Jan. 60(1):85-90. [QxMD MEDLINE Link].

30. Meguro K, Ishii H, Yamaguchi S. Prevalence of dementia and dementing diseases in Japan: the Tajiri project. Arch Neurol. 2002 Jul. 59(7):1109-14. [QxMD MEDLINE Link].

31. Mok VC, Liu T, Lam WW, Wong A, Hu X, Guo L, et al. Neuroimaging predictors of cognitive impairment in confluent white matter lesion: volumetric analyses of 99 brain regions. Dement Geriatr Cogn Disord. 2008. 25(1):67-73. [QxMD MEDLINE Link].

32. Mok VC, Wong A, Lam WW. Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry. 2004 Apr. 75(4):560-6. [QxMD MEDLINE Link].

33. Moretti R, Torre P, Antonello RM, Cazzato G, Pizzolato G. Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia. Am J Alzheimers Dis Other Demen. 2008 Apr-May. 23(2):167-76. [QxMD MEDLINE Link].

34. Morris JC. The nosology of dementia. Neurol Clin. 2000 Nov. 18(4):773-88. [QxMD MEDLINE Link].

35. Orgogozo JM, Rigaud AS, Stoffler A. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke. 2002 Jul. 33(7):1834-9. [QxMD MEDLINE Link].

36. Polidori MC, Pientka L. A brief update on dementia prevention. Z Gerontol Geriatr. 2012 Jan. 45(1):7-10. [QxMD MEDLINE Link].

37. Quinn J. Vascular dementia. J Am Med Dir Assoc. 2003 Nov-Dec. 4(6 Suppl):S155-61. [QxMD MEDLINE Link].

38. Rao R. The role of carotid stenosis in vascular cognitive impairment. J Neurol Sci. 2002 Nov 15. 203-204:103-7. [QxMD MEDLINE Link].

39. Roman GC, Tatemichi TK, Erkinjuntti T. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993 Feb. 43(2):250-60. [QxMD MEDLINE Link].

40. Sha MC, Callahan CM. The efficacy of pentoxifylline in the treatment of vascular dementia: a systematic review. Alzheimer Dis Assoc Disord. 2003 Jan-Mar. 17(1):46-54. [QxMD MEDLINE Link].

41. Vermeer SE, Prins ND, den Heijer T. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003 Mar 27. 348(13):1215-22. [QxMD MEDLINE Link].

Jasvinder Chawla, MD, MBA Chief of Neurology, Hines Veterans Affairs Hospital; Professor of Neurology, Loyola University Medical Center

Jasvinder Chawla, MD, MBA is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Clinical Neurophysiology Society, American Medical Association

Disclosure: Nothing to disclose.

Jaime Grutzendler, MD Assistant Professor, Department of Neurology and Physiology, Northwestern University School of Medicine

Jaime Grutzendler, MD is a member of the following medical societies: American Academy of Neurology, Society for Neuroscience

Disclosure: Nothing to disclose.

Giovanni d'Avossa, MD Lecturer, School of Psychology, Bangor University; NHS Honorary Consultant in Neurology

Disclosure: Nothing to disclose.

Fredy J Revilla, MD, FAAN, FANA Clinical Professor, University of South Carolina School of Medicine, Greenville; Chief, Division of Neurology, UMG Neuroscience Associates, Prisma Health-Upstate

Fredy J Revilla, MD, FAAN, FANA is a member of the following medical societies: American Academy of Neurology, American Neurological Association, Huntington Study Group, International Parkinson and Movement Disorder Society, Parkinson Study Group, Society for Neuroscience

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Jorge C Kattah, MD Head, Associate Program Director, Professor, Department of Neurology, University of Illinois College of Medicine at Peoria

Jorge C Kattah, MD is a member of the following medical societies: American Academy of Neurology, American Neurological Association, New York Academy of Sciences

Disclosure: Nothing to disclose.

Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM Adjunct Associate Professor of Neurology, University of Missouri-Columbia School of Medicine; Medical Director of St Mary's Stroke Program, SSM Neurosciences Institute, SSM Health

Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Headache Society

Disclosure: Nothing to disclose.

Christopher Luzzio, MD Clinical Assistant Professor, Department of Neurology, University of Wisconsin at Madison School of Medicine and Public Health

Christopher Luzzio, MD is a member of the following medical societies: American Academy of Neurology

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article